Previous work focused on the role of differential miRNA expression in the triple-negative breast cancer (TNBC) histologic subtype (estrogen receptor–negative, progesterone receptor–negative, HER2-negative (45, 46). Here, ERBB2 is linked to triple-negative breast carcinoma.